Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
Launched by NORTHWESTERN UNIVERSITY · Jan 26, 2003
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving the early detection and prevention of ovarian cancer, particularly for women who are at higher risk. The study is collecting blood samples and health information to help researchers develop better methods for identifying ovarian cancer at its earliest stages. If you're a woman between 18 and 80 years old and have a family history of ovarian or related cancers, or if you're undergoing surgery for a gynecological issue, you might be eligible to participate in this study.
Participants can expect to provide some health information and samples, which will contribute to important research aimed at preventing ovarian cancer. The trial is currently recruiting, so if you're interested, you may want to discuss this opportunity with your healthcare provider. This research is crucial as it aims to help find better ways to identify and potentially prevent ovarian cancer, making it an important step for women's health.
Gender
FEMALE
Eligibility criteria
- DISEASE CHARACTERISTICS:
- * Meets one of the following criteria:
- * Considered to be at increased risk for developing ovarian cancer, as defined by one of the following:
- • Has at least one first-degree relative (mother, sister, or daughter) with ovarian, primary peritoneal, or fallopian tube cancer
- • Has at least two first or second degree relatives diagnosed before age 50 with either ovarian, primary peritoneal, fallopian tube, and/or pancreatic cancer who have tested positive for hereditary cancer syndrome that includes an increased risk of gynecologic cancer (e.g., BRCA1/2 or Lynch Syndrome)or have increased risk as deemed by a certified genetic counselor
- • A personal or family history of a hereditary cancer syndrome that includes an increased risk of gynecologic cancer
- • Increased risk as deemed by a certified genetic counselor
- * Undergoing surgery for a gynecologic condition, including any of the following:
- • Diagnosis of a reproductive cancer
- • Benign gynecological condition (e.g., uterine leiomyomata, endometriosis, pelvic inflammatory disease, or follicular or corpus luteum ovarian cysts)
- • Highly suspicious adnexal mass
- • Risk-reducing prophylactic oophorectomy
- PATIENT CHARACTERISTICS:
- • Age
- • Between the ages of 18 and 80
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Lee P. Shulman, MD
Study Chair
Robert H. Lurie Cancer Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials